Artivion, Inc. (AORT)
USD 27.79
(-3.84%)
USD 27.79
(-3.84%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 354 Million USD | 12.82% |
| 2022 | 313.78 Million USD | 5.0% |
| 2021 | 298.83 Million USD | 18.01% |
| 2020 | 253.22 Million USD | -8.32% |
| 2019 | 276.22 Million USD | 5.09% |
| 2018 | 262.84 Million USD | 38.55% |
| 2017 | 189.7 Million USD | 5.17% |
| 2016 | 180.38 Million USD | 23.63% |
| 2015 | 145.89 Million USD | 0.87% |
| 2014 | 144.64 Million USD | 2.75% |
| 2013 | 140.76 Million USD | 6.87% |
| 2012 | 131.71 Million USD | 10.11% |
| 2011 | 119.62 Million USD | 2.56% |
| 2010 | 116.64 Million USD | 4.44% |
| 2009 | 111.68 Million USD | 6.31% |
| 2008 | 105.05 Million USD | 10.87% |
| 2007 | 94.76 Million USD | 16.54% |
| 2006 | 81.31 Million USD | 17.36% |
| 2005 | 69.28 Million USD | 11.06% |
| 2004 | 62.38 Million USD | 4.79% |
| 2003 | 59.53 Million USD | -23.48% |
| 2002 | 77.79 Million USD | -11.26% |
| 2001 | 87.67 Million USD | 13.72% |
| 2000 | 77.09 Million USD | 15.55% |
| 1999 | 66.72 Million USD | 9.92% |
| 1998 | 60.7 Million USD | 19.25% |
| 1997 | 50.9 Million USD | 37.57% |
| 1996 | 37 Million USD | 27.59% |
| 1995 | 29 Million USD | 22.88% |
| 1994 | 23.6 Million USD | 11.32% |
| 1993 | 21.2 Million USD | 8.16% |
| 1992 | 19.6 Million USD | 28.1% |
| 1991 | 15.3 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 97.43 Million USD | 4.02% |
| 2024 Q2 | 98.01 Million USD | 0.6% |
| 2023 Q2 | 89.25 Million USD | 7.24% |
| 2023 Q4 | 93.67 Million USD | 6.62% |
| 2023 FY | 354 Million USD | 12.82% |
| 2023 Q1 | 83.22 Million USD | 4.83% |
| 2023 Q3 | 87.85 Million USD | -1.57% |
| 2022 FY | 313.78 Million USD | 5.0% |
| 2022 Q1 | 77.21 Million USD | -2.75% |
| 2022 Q2 | 80.34 Million USD | 4.05% |
| 2022 Q3 | 76.83 Million USD | -4.36% |
| 2022 Q4 | 79.39 Million USD | 3.33% |
| 2021 Q1 | 71.08 Million USD | 4.7% |
| 2021 Q2 | 76.14 Million USD | 7.12% |
| 2021 Q3 | 72.2 Million USD | -5.18% |
| 2021 Q4 | 79.39 Million USD | 9.95% |
| 2021 FY | 298.83 Million USD | 18.01% |
| 2020 FY | 253.22 Million USD | -8.32% |
| 2020 Q3 | 65.13 Million USD | 21.13% |
| 2020 Q1 | 66.42 Million USD | -4.69% |
| 2020 Q2 | 53.77 Million USD | -19.05% |
| 2020 Q4 | 67.89 Million USD | 4.25% |
| 2019 Q2 | 71.13 Million USD | 5.38% |
| 2019 FY | 276.22 Million USD | 5.09% |
| 2019 Q1 | 67.5 Million USD | -0.43% |
| 2019 Q3 | 67.88 Million USD | -4.58% |
| 2019 Q4 | 69.69 Million USD | 2.68% |
| 2018 Q2 | 68.49 Million USD | 10.57% |
| 2018 Q4 | 67.79 Million USD | 4.96% |
| 2018 Q3 | 64.59 Million USD | -5.69% |
| 2018 FY | 262.84 Million USD | 38.55% |
| 2018 Q1 | 61.94 Million USD | 17.27% |
| 2017 Q4 | 52.82 Million USD | 20.06% |
| 2017 Q3 | 43.99 Million USD | -7.99% |
| 2017 FY | 189.7 Million USD | 5.17% |
| 2017 Q2 | 47.81 Million USD | 6.12% |
| 2017 Q1 | 45.05 Million USD | 0.07% |
| 2016 Q2 | 47.08 Million USD | 9.45% |
| 2016 FY | 180.38 Million USD | 23.63% |
| 2016 Q1 | 43.01 Million USD | 7.98% |
| 2016 Q4 | 45.02 Million USD | -0.49% |
| 2016 Q3 | 45.25 Million USD | -3.89% |
| 2015 Q3 | 36.7 Million USD | 3.31% |
| 2015 Q2 | 35.52 Million USD | 5.01% |
| 2015 Q4 | 39.83 Million USD | 8.54% |
| 2015 FY | 145.89 Million USD | 0.87% |
| 2015 Q1 | 33.83 Million USD | -8.94% |
| 2014 Q4 | 37.15 Million USD | 0.22% |
| 2014 Q3 | 37.06 Million USD | 6.86% |
| 2014 Q1 | 35.73 Million USD | 0.77% |
| 2014 Q2 | 34.69 Million USD | -2.91% |
| 2014 FY | 144.64 Million USD | 2.75% |
| 2013 Q1 | 35.53 Million USD | 8.34% |
| 2013 Q2 | 33.52 Million USD | -5.67% |
| 2013 FY | 140.76 Million USD | 6.87% |
| 2013 Q4 | 35.45 Million USD | -2.19% |
| 2013 Q3 | 36.25 Million USD | 8.14% |
| 2012 Q4 | 32.8 Million USD | -1.88% |
| 2012 Q3 | 33.42 Million USD | 0.73% |
| 2012 Q2 | 33.18 Million USD | 2.75% |
| 2012 Q1 | 32.3 Million USD | 6.26% |
| 2012 FY | 131.71 Million USD | 10.11% |
| 2011 Q1 | 30.19 Million USD | 3.33% |
| 2011 Q4 | 30.39 Million USD | 2.51% |
| 2011 Q2 | 29.37 Million USD | -2.71% |
| 2011 Q3 | 29.65 Million USD | 0.94% |
| 2011 FY | 119.62 Million USD | 2.56% |
| 2010 Q4 | 29.22 Million USD | 2.74% |
| 2010 Q1 | 29.71 Million USD | 3.85% |
| 2010 Q2 | 29.26 Million USD | -1.53% |
| 2010 Q3 | 28.44 Million USD | -2.8% |
| 2010 FY | 116.64 Million USD | 4.44% |
| 2009 Q1 | 26.68 Million USD | 4.53% |
| 2009 Q3 | 28.21 Million USD | 100098.84% |
| 2009 FY | 111.68 Million USD | 6.31% |
| 2009 Q4 | 28.61 Million USD | 1.4% |
| 2009 Q2 | 28.16 Thousand USD | -99.89% |
| 2008 Q3 | 26.8 Million USD | -1.29% |
| 2008 Q1 | 25.56 Million USD | 1.99% |
| 2008 FY | 105.05 Million USD | 10.87% |
| 2008 Q2 | 27.15 Million USD | 6.21% |
| 2008 Q4 | 25.53 Million USD | -4.75% |
| 2007 FY | 94.76 Million USD | 16.54% |
| 2007 Q4 | 25.06 Million USD | 13.12% |
| 2007 Q3 | 22.16 Million USD | -3.7% |
| 2007 Q2 | 23.01 Million USD | -6.17% |
| 2007 Q1 | 24.52 Million USD | 16.28% |
| 2006 FY | 81.31 Million USD | 17.36% |
| 2006 Q4 | 21.09 Million USD | 5.36% |
| 2006 Q3 | 20.01 Million USD | -3.55% |
| 2006 Q2 | 20.75 Million USD | 6.71% |
| 2006 Q1 | 19.44 Million USD | 8.28% |
| 2005 FY | 69.28 Million USD | 11.06% |
| 2005 Q1 | 17.66 Million USD | 11.34% |
| 2005 Q3 | 16.45 Million USD | -4.3% |
| 2005 Q4 | 17.96 Million USD | 9.13% |
| 2005 Q2 | 17.19 Million USD | -2.64% |
| 2004 Q4 | 15.86 Million USD | -1.56% |
| 2004 Q2 | 15.31 Million USD | 1.51% |
| 2004 Q1 | 15.08 Million USD | 17.84% |
| 2004 FY | 62.38 Million USD | 4.79% |
| 2004 Q3 | 16.11 Million USD | 5.25% |
| 2003 FY | 59.53 Million USD | -23.48% |
| 2003 Q4 | 12.8 Million USD | -15.2% |
| 2003 Q3 | 15.09 Million USD | -3.92% |
| 2003 Q1 | 15.92 Million USD | 30.8% |
| 2003 Q2 | 15.71 Million USD | -1.3% |
| 2002 Q4 | 12.17 Million USD | -27.94% |
| 2002 Q3 | 16.88 Million USD | -27.4% |
| 2002 Q2 | 23.26 Million USD | -8.66% |
| 2002 Q1 | 25.47 Million USD | 15.91% |
| 2002 FY | 77.79 Million USD | -11.26% |
| 2001 Q1 | 21.43 Million USD | 15.88% |
| 2001 FY | 87.67 Million USD | 13.72% |
| 2001 Q4 | 21.97 Million USD | -2.62% |
| 2001 Q3 | 22.56 Million USD | 4.01% |
| 2001 Q2 | 21.69 Million USD | 1.24% |
| 2000 FY | 77.09 Million USD | 15.55% |
| 2000 Q4 | 18.49 Million USD | -5.27% |
| 2000 Q1 | 19.62 Million USD | 18.77% |
| 2000 Q2 | 19.45 Million USD | -0.86% |
| 2000 Q3 | 19.52 Million USD | 0.36% |
| 1999 Q2 | 17.4 Million USD | 6.75% |
| 1999 Q1 | 16.3 Million USD | 11.64% |
| 1999 Q4 | 16.52 Million USD | 0.13% |
| 1999 Q3 | 16.5 Million USD | -5.17% |
| 1999 FY | 66.72 Million USD | 9.92% |
| 1998 FY | 60.7 Million USD | 19.25% |
| 1998 Q1 | 14.6 Million USD | 11.45% |
| 1998 Q2 | 16.3 Million USD | 11.64% |
| 1998 Q3 | 16 Million USD | -1.84% |
| 1998 Q4 | 14.6 Million USD | -8.75% |
| 1997 Q1 | 10.4 Million USD | 22.35% |
| 1997 FY | 50.9 Million USD | 37.57% |
| 1997 Q3 | 14.6 Million USD | 14.96% |
| 1997 Q4 | 13.1 Million USD | -10.27% |
| 1997 Q2 | 12.7 Million USD | 22.12% |
| 1996 Q4 | 8.5 Million USD | -18.27% |
| 1996 Q3 | 10.4 Million USD | 7.22% |
| 1996 Q2 | 9.7 Million USD | 16.87% |
| 1996 Q1 | 8.3 Million USD | 22.06% |
| 1996 FY | 37 Million USD | 27.59% |
| 1995 Q2 | 7.2 Million USD | 9.09% |
| 1995 Q3 | 8.3 Million USD | 15.28% |
| 1995 Q4 | 6.8 Million USD | -18.07% |
| 1995 FY | 29 Million USD | 22.88% |
| 1995 Q1 | 6.6 Million USD | 13.79% |
| 1994 Q2 | 5.9 Million USD | 11.32% |
| 1994 Q4 | 5.8 Million USD | -12.12% |
| 1994 FY | 23.6 Million USD | 11.32% |
| 1994 Q1 | 5.3 Million USD | 0.0% |
| 1994 Q3 | 6.6 Million USD | 11.86% |
| 1993 Q2 | 5.2 Million USD | 10.64% |
| 1993 FY | 21.2 Million USD | 8.16% |
| 1993 Q1 | 4.7 Million USD | 2.17% |
| 1993 Q3 | 6 Million USD | 15.38% |
| 1993 Q4 | 5.3 Million USD | -11.67% |
| 1992 FY | 19.6 Million USD | 28.1% |
| 1992 Q1 | 4.5 Million USD | 4.65% |
| 1992 Q3 | 5.3 Million USD | 0.0% |
| 1992 Q2 | 5.3 Million USD | 17.78% |
| 1992 Q4 | 4.6 Million USD | -13.21% |
| 1991 Q1 | 2.9 Million USD | 0.0% |
| 1991 Q2 | 3.6 Million USD | 24.14% |
| 1991 Q3 | 4.5 Million USD | 25.0% |
| 1991 Q4 | 4.3 Million USD | -4.44% |
| 1991 FY | 15.3 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Abbott Laboratories | 40.1 Billion USD | 99.117% |
| Allurion Technologies Inc. | 53.46 Million USD | -562.098% |
| Avanos Medical, Inc. | 673.3 Million USD | 47.423% |
| Butterfly Network, Inc. | 65.9 Million USD | -437.184% |
| Butterfly Network, Inc. | 65.9 Million USD | -437.184% |
| Bio-Rad Laboratories, Inc. | 2.67 Billion USD | 86.748% |
| Boston Scientific Corporation | 14.24 Billion USD | 97.514% |
| Perspective Therapeutics, Inc. | 7.1 Million USD | -4883.164% |
| CONMED Corporation | 1.24 Billion USD | 71.473% |
| Edwards Lifesciences Corporation | 6 Billion USD | 94.105% |
| Paragon 28, Inc. | 216.38 Million USD | -63.596% |
| Glaukos Corporation | 314.71 Million USD | -12.485% |
| Globus Medical, Inc. | 1.56 Billion USD | 77.43% |
| Inspire Medical Systems, Inc. | 624.79 Million USD | 43.341% |
| Integer Holdings Corporation | 1.59 Billion USD | 77.829% |
| Medtronic plc | 32.36 Billion USD | 98.906% |
| Nevro Corp. | 425.17 Million USD | 16.739% |
| Owlet, Inc. | 54.01 Million USD | -555.442% |
| Penumbra, Inc. | 1.05 Billion USD | 66.557% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 5.54 Billion USD | 93.62% |
| Sonendo, Inc. | 43.86 Million USD | -707.031% |
| STERIS plc | 5.13 Billion USD | 93.111% |
| Stryker Corporation | 20.49 Billion USD | 98.273% |
| Vapotherm, Inc. | 68.66 Million USD | -415.522% |
| Zimmer Biomet Holdings, Inc. | 7.39 Billion USD | 95.212% |